ImmunityBio, Inc.: director Cheryl Cohen sold 81,056 shares

What happened Cheryl Cohen, director, exercised 55,979 shares at $2.98 on Oct 2, 2026 for $166,817. The filing also reports an open-market sale of 81,056 shares at $10.50 on Oct 2, 2026 for $851,088. The filing shows a derivative disposition of 55,979 shares at $0.00 on Oct 2, 2026.

Key details

• Transaction dates and prices: Oct 2, 2026 — exercised 55,979 shares @ $2.98; sold 81,056 shares @ $10.50; derivative disposition 55,979 shares @ $0.00.
• Shares owned after the transaction: not reported on this Form 4.
• Footnotes: sale effected pursuant to a Rule 10b5-1 trading plan entered Feb 27, 2026 (footnote F1).
• Filing timing: Form filed Oct 6, 2026; period of report Oct 2, 2026.

Why it may matter The filing shows an options exercise and a contemporaneous market sale; it does not indicate the sale was part of a cashless exercise. The sale was reported as executed under a Rule 10b5-1 plan. This filing does not show why the insider traded or why the company acted.